Latest Articles
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
Published: Jan. 20, 2025, 8:21 a.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews
Published: Jan. 20, 2025, 7:28 a.m.
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment - TipRanks
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks
Published: Jan. 20, 2025, 7:19 a.m.
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer - FirstWord Pharma
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer FirstWord Pharma
Published: Jan. 20, 2025, 7:14 a.m.
Dedicated endometriosis clinic fills care gap - Bdaily News
Dedicated endometriosis clinic fills care gap Bdaily News
Published: Jan. 20, 2025, 6:59 a.m.
Endometriosis poses substantial burden on Australia's health system - MSN
Endometriosis poses substantial burden on Australia's health system MSN
Published: Jan. 20, 2025, 6:23 a.m.
Halsey Reflects on Health Journey After Lupus & T-Cell Disorder Struggles - - HOLR Magazine
Halsey Reflects on Health Journey After Lupus & T-Cell Disorder Struggles - HOLR Magazine
Published: Jan. 20, 2025, 5:50 a.m.
Mum discovers 16 fibroids following years of misdiagnosed menstrual pain - Surrey Live
Mum discovers 16 fibroids following years of misdiagnosed menstrual pain Surrey Live
Published: Jan. 20, 2025, 2:32 a.m.
FORTUNE IN FULL BLOOM - The Star Online
FORTUNE IN FULL BLOOM The Star Online
Published: Jan. 20, 2025, 1:42 a.m.
Link copied to clipboard!